Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Apple Inc (AAPL) vs BioNTech SE - ADR (BNTX) Price & Performance

BioNTech SE - ADRTrade

Price performance (Past 24H)

Key statistics

Apple Inc vs BioNTech SE - ADR — how do they compare? Apple Inc trades at $304.75 (market cap $4.45T), while BioNTech SE - ADR trades at $92.8 (market cap $23.31B). The key difference: Apple Inc is far larger — about 190.9× BioNTech SE - ADR's market cap, and Apple Inc pays a 0.35% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.

AAPLBNTX
Market Cap
$4.45T$23.31B
Volume
100,358,844
Sector
TechnologyHealth
52-Week High
$340.08$119.34
52-Week Low
$224.90$83.89
Enterprise Value
$4.47T$6.60B
Dividend Yield
0.35%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Apple Inc

AAPL trades at $308.26, down 1.62% on the day, with a bearish technical signal and near-term support at $306. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.02 exceeding the $1.89 estimate. Revenue grew to $416.16B in 2025, and net income margin improved to 27.62%. Analyst consensus is bullish with a $337.63 price target, though recent news highlights union disputes and potential Q3 earnings pressure.

Outlook remains positive driven by AI opportunities and a massive device ecosystem, but risks include weaker iPhone sales, regulatory scrutiny, and union tensions. The stock offers growth potential with solid cash flow, yet investors should weigh near-term headwinds against long-term strengths.

BioNTech SE - ADR

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Apple Inc

Apple Inc. designs, manufactures, and markets personal computers and related personal computing and mobile communication devices along with a variety of related software, services, peripherals, and networking solutions. Apple sells its products worldwide through its online stores, its retail stores, its direct sales force, third-party wholesalers, and resellers.

Read more on AAPL

About BioNTech SE - ADR

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.

Read more on BNTX